• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Comprehensive analysis of GVHD regulated cells by high dimensional cytometry and identification of prognostic factors

Research Project

Project/Area Number 15K09508
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Hematology
Research InstitutionSapporo Medical University

Principal Investigator

Murase Kazuyuki  札幌医科大学, 医学部, 講師 (90444918)

Co-Investigator(Kenkyū-buntansha) 佐藤 勉  札幌医科大学, 医学部, 講師 (40404602)
小船 雅義  札幌医科大学, 医学部, 准教授 (90336389)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
KeywordsGVHD / Treg / 高次元サイトメトリー / 高次元サイトメトリー法 / BH3 profiling
Outline of Final Research Achievements

In chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation, individual differences in severity are large, so identification of GVHD predictive factors and development of a novel control method are desired.
In this study, we comprehensively analyzed cGVHD regulatory cells after transplantation by using high-dimensional cytometry in combination with BH3 profiling and clarified the usefulness of IL-2 therapy.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (10 results)

All 2016 2015 2014

All Journal Article (10 results) (of which Int'l Joint Research: 3 results,  Peer Reviewed: 10 results,  Open Access: 7 results,  Acknowledgement Compliant: 1 results)

  • [Journal Article] The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.2016

    • Author(s)
      Kamihara Y, Murase K, Kato J, et al
    • Journal Title

      Oncotarget

      Volume: 27 Issue: 39 Pages: 64330-64341

    • DOI

      10.18632/oncotarget.11830

    • NAID

      120006576953

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma.2016

    • Author(s)
      Ibata S, Murase K, Kato J, et al
    • Journal Title

      Cancer Chemother Pharmacol.

      Volume: 78 Pages: 1041-1049

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.2016

    • Author(s)
      Okagawa Y, Murase K, Kato J, et al
    • Journal Title

      PLoS One.

      Volume: 15 Issue: 12 Pages: e0168355-e0168355

    • DOI

      10.1371/journal.pone.0168355

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells.2016

    • Author(s)
      Hashimoto A, Murase K, Kato J. et al
    • Journal Title

      PLoS One

      Volume: 31 Issue: 3 Pages: e0152823-e0152823

    • DOI

      10.1371/journal.pone.0152823

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.2016

    • Author(s)
      Horiguchi H, Murase K, Kato J. et al
    • Journal Title

      Haematologica

      Volume: 101 Issue: 4 Pages: 437-447

    • DOI

      10.3324/haematol.2015.134932

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Neurolymphomatosis of the sciatic nerve diagnosed by FDG-PET/CT2016

    • Author(s)
      Usami M, Murase K, Kato J. et al
    • Journal Title

      Rinsho Ketsueki

      Volume: 57 Issue: 1 Pages: 52-55

    • DOI

      10.11406/rinketsu.57.52

    • NAID

      130005125846

    • ISSN
      0485-1439, 1882-0824
    • Related Report
      2015 Research-status Report
    • Peer Reviewed
  • [Journal Article] BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer.2015

    • Author(s)
      Kubo T, Murase K, Kato J. et al
    • Journal Title

      Gastric Cancer.

      Volume: 20

    • NAID

      40020881713

    • Related Report
      2015 Research-status Report
    • Peer Reviewed
  • [Journal Article] Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.2015

    • Author(s)
      Hirayama Y, Ishitani K, Sato Y, Iyama S, Takada K, Murase K, Kuroda H, Nagamachi Y, Konuma Y, Fujimi A, Sagawa T, Ono K, Horiguchi H, Terui T, Koike K, Kusakabe T, Sato T, Takimoto R, Kobune M, Kato J
    • Journal Title

      Int J Clin Oncol

      Volume: 20 Issue: 5 Pages: 866-871

    • DOI

      10.1007/s10147-015-0810-y

    • Related Report
      2015 Research-status Report
    • Peer Reviewed
  • [Journal Article] A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer.2015

    • Author(s)
      Sato Y, Ohnuma H, Hirakawa M, Takahashi M, Osuga T, Okagawa Y, Murase K, Takada K, Kawano Y, Iyama S, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Okita K, Mizuguchi T, Furuhata T, Hirata K, Kato J
    • Journal Title

      Cancer Chemother Pharmacol

      Volume: 75 Issue: 3 Pages: 587-597

    • DOI

      10.1007/s00280-014-2672-9

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells2014

    • Author(s)
      Tamura F, Sato Y, Hirakawa M, Yoshida M, Ono M, Osuga T, Okagawa Y, Uemura N, Arihara Y, Murase K, Kawano Y, Iyama S, Takada K, Hayashi T, Sato T, Miyanishi K, Kobune M, Takimoto R, Kato J.
    • Journal Title

      Gastric Cancer

      Volume: 23 Issue: 1 Pages: 85-97

    • DOI

      10.1007/s10120-014-0454-z

    • NAID

      40020700032

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi